Global CD244 (2B4) Antibody Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global CD244 (2B4) Antibody Market Insights, Forecast to 2034
CD244 (2B4) Antibody is an antibody directed against the CD244 protein in the human immune system.
Market Analysis and InsightsGlobal CD244 (2B4) Antibody Market
Global CD244 (2B4) Antibody market is expected to reach to US$ 443.5 million in 2024, with a positive growth of %, compared with US$ 394.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CD244 (2B4) Antibody industry is evaluated to reach US$ 894.4 million in 2029. The CAGR will be 12.4% during 2024 to 2029.
CD244 is a cell surface molecule that belongs to the immunoglobulin superfamily and is mainly expressed on natural killer cells, T cells and certain subsets of B cells. By binding to the CD244 molecule, this antibody can regulate the activation, proliferation and function of immune cells, thereby affecting the regulation and effect of the immune response. Since CD244 plays an important role in regulating immune cell interactions, the potential application of CD244 antibodies in immunotherapy research and the treatment of tumors, autoimmune diseases and other diseases has attracted much attention.
Report Covers
This report presents an overview of global CD244 (2B4) Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global CD244 (2B4) Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Thermo Fisher
BioLegend
Abbexa
Abcam
Cell Signaling Technology, Inc.
Arigo Biolaboratories Corp.
Boster Biological Technology
GeneTex
MyBiosource, Inc.
CUSABIO
Creative Diagnostics
Bio-Techne
AMSBIO
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, CD244 (2B4) Antibody introduction, etc. CD244 (2B4) Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of CD244 (2B4) Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal CD244 (2B4) Antibody Market
Global CD244 (2B4) Antibody market is expected to reach to US$ 443.5 million in 2024, with a positive growth of %, compared with US$ 394.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CD244 (2B4) Antibody industry is evaluated to reach US$ 894.4 million in 2029. The CAGR will be 12.4% during 2024 to 2029.
CD244 is a cell surface molecule that belongs to the immunoglobulin superfamily and is mainly expressed on natural killer cells, T cells and certain subsets of B cells. By binding to the CD244 molecule, this antibody can regulate the activation, proliferation and function of immune cells, thereby affecting the regulation and effect of the immune response. Since CD244 plays an important role in regulating immune cell interactions, the potential application of CD244 antibodies in immunotherapy research and the treatment of tumors, autoimmune diseases and other diseases has attracted much attention.
Report Covers
This report presents an overview of global CD244 (2B4) Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global CD244 (2B4) Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Thermo Fisher
BioLegend
Abbexa
Abcam
Cell Signaling Technology, Inc.
Arigo Biolaboratories Corp.
Boster Biological Technology
GeneTex
MyBiosource, Inc.
CUSABIO
Creative Diagnostics
Bio-Techne
AMSBIO
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, CD244 (2B4) Antibody introduction, etc. CD244 (2B4) Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of CD244 (2B4) Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports